Experimental Therapeutics in Treatment-Resistant Major Depressive Disorder
Journal of Experimental Pharmacology, 2021 Mandeep Kaur,1 Marsal Sanches2 1Department of Behavioral Medicine, Cone Health, Greensboro, NC, USA; 2UT Health Center of Excellence on Mood Disorders, Faillace Department of Psychiatry & Behavioral Sciences, McGovern Medical School, Houston, TX ...
Kaur M, Sanches M
doaj +5 more sources
Epidemiology of treatment resistant depression among major depressive disorder patients in Israel
BMC Psychiatry, 2022 Introduction Major depressive disorder (MDD) is one of the most common mental disorders worldwide, estimated to affect 10–15% of the population per year.
Sarah Sharman Moser +5 more
doaj +3 more sources
Treatment-resistant major depressive disorder and assisted dying [PDF]
Journal of Medical Ethics, 2015 Competent patients suffering from treatment-resistant depressive disorder should be treated no different in the context of assisted dying to other patients suffering from chronic conditions that render their lives permanently not worth living to them.
Schuklenk, Udo, van de Vathorst, Suzanne
openaire +3 more sources
European Psychiatry, 2021 Introduction Sleep disturbance specifically insomnia, non-restorative sleep, and hypersomnia are common symptoms of major depressive disorder (MDD).
A.I. Sonmez +7 more
doaj +1 more source
Lamotrigine in the treatment of schizoaffective disorder [PDF]
, 1998 There is accumulating evidence for the efficacy of lamotrigine in the treatment of bipolar disorder, including bipolar depression, both as monotherapy and in combination with sodium valproate.
Erfurth, Andreas +2 more
core +1 more source
Cushing's syndrome masquerading as treatment resistant depression
Indian Journal of Psychological Medicine, 2016 Treatment resistant depression (TRD) is a common clinical occurrence among patients treated for major depressive disorder. A significant proportion of patients remain significantly depressed in spite of aggressive pharmacological and psychotherapeutic ...
B N Anil Kumar, Sandeep Grover
doaj +1 more source
Brain Sciences, 2022 Major depressive disorder is a leading cause of disability worldwide and a major contributor to the overall global burden of disease. While there are several options for antidepressant treatment, only about 40–60% of patients respond to initial ...
Theano Gkesoglou +5 more
doaj +1 more source
Maintenance deep transcranial magnetic stimulation sessions are associated with reduced depressive relapses in patients with unipolar or bipolar depression [PDF]
, 2015 Introduction: Deep transcranial magnetic stimulation (dTMS) is a new form of TMS allowing safe stimulation of deep brain regions. The objective of this preliminary study was to assess the role of dTMS maintenance sessions in protecting patients with ...
ANGELETTI, Gloria +11 more
core +2 more sources
Treatment‐resistant major depressive disorder: Canadian expert consensus on definition and assessment [PDF]
Depression and Anxiety, 2021 Treatment-resistant depression (TRD) is a debilitating chronic mental illness that confers increased morbidity and mortality, decreases the quality of life, impairs occupational, social, and offspring development, and translates into increased costs on the healthcare system.
Yuri E. Rybak +15 more
openaire +4 more sources
Comparing the effects of repetitive transcranial magnetic stimulation and electroconvulsive therapy in the treatment of depression : a systematic review and meta-analysis [PDF]
, 2014 Electroconvulsive therapy (ECT) is the longest standing psychiatric treatment available and has unequivocal benefit in severe depression. However this treatment comes with a number of side effects such as memory impairment.
Micallef-Trigona, Beppe
core +4 more sources